Clinical Trial: Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia

Brief Summary:

To investigate the pharmacodynamics, pharmacokinetics and safety of 7-day-repeated doses of FYU-981 administered orally to male hyperuricemic patients with uric acid-overproduction or uric acid-underexcretion type.

In addition, to investigate the additive effects of the combination of FYU-981 and topiroxostat administered orally to male hyperuricemic patients with uric acid-overproduction type.